OCTOBER 2024RiverVest Venture Partners Welcomes Nafise Masoumi as Senior Associate Nafise Masoumi, PhDST. LOUIS--(October 16, 2024)--Life sciences venture capital firm RiverVest Venture Partners today announced that Nafise Masoumi, Ph.D. has joined the firm as senior associate based in the San Diego office, where she will focus...
JULY 2024RiverVest Venture Partners Announces Promotions /*! elementor - v3.22.0 - 26-06-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (July 18, 2024)ST. LOUIS, July 18, 2024– RiverVest Venture Partners today announced the promotions of two members of its team. Andrew Kleiboeker has been promoted to associate, and...
June 2024O'Donnell Honored for Entrepreneurial Achievement by UC San Diego's Rady School of Management /*! elementor - v3.21.0 - 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Niall O'Donnell, Ph.D. RiverVest Managing Director San Diego, CA (June 5, 2024) – UC San Diego’s Rady School of Management named Niall O’Donnell,...
DECEMBER 2023RiverVest Venture Partners Promotes Karen Spilizewski and Isaac Zike to Managing Director and Pascal Krotee to Principal /*! elementor - v3.22.0 - 26-06-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (December 14, 2023)ST. LOUIS, December 14, 2023 – RiverVest Venture Partners today announced the promotions of...
November 2023RiverVest's Pascal Krotee Wins Life Science Catalyst Award /*! elementor - v3.17.0 - 01-11-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Pascal Krotee, Ph.D. RiverVest Senior Associate San Diego, CA (November 1, 2023) – Biocom California today announced the winners of its Eighth Annual Life Science Catalyst Award. RiverVest...
July 2023RiverVest's Niall O'Donnell Discusses State of Biotech VC in 2023 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} RiverVest Managing Director Niall O'Donnell, Ph.D.ST. LOUIS, MO (July 21, 2023) – From the St. Louis Business Journal, Beyond the List: St. Louis area's largest...
March 2023RiverVest Mourns Passing of William A. Peck, MD,RiverVest Scientific Advisory Board Founding Member /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} William A. Peck, MDSeptember 28, 1933 - February 22, 2023In MemoriamWe mourn the passing of William A. Peck, MD, who as the...
SEPT 2022Portfolio Company Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 7, 2022)Read the Press ReleaseGood Therapeutics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive...
AUG 2022Teleflex to Acquire Portfolio Company Standard Bariatrics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 22, 2022)Read the Press ReleaseST. LOUIS (August 22, 2022) – Standard Bariatrics – a RiverVest Venture Fund IV portfolio company – has entered into a...
AUG 2021Portfolio Company Amplyx Pharmaceuticals Acquired by Pfizer /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 26, 2021)Read the Press ReleaseNEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to...
MAR 2021What's next for RiverVest Venture Partners after raising its largest-ever investment fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 24, 2021)Read the Press ReleaseST. LOUIS, MO (Mar. 24, 2021) – From the St. Louis Business JournalRiverVest Venture Partners has...
MAR 2021RiverVest Venture Partners Closes $275 Million Life Sciences Fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 23, 2021)Oversubscribed fund to continue investing in high-impact biopharma and medical device innovationST. LOUIS (March 23, 2021) – RiverVest Venture Partners, a leading...
FEB 2021Pascal Krotee Joins RiverVest as Senior Associate /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (February 16, 2021)St. Louis, MO (Feb 16, 2021) – Life science venture capital firm RiverVest continues to expand its team with the addition of Pascal Krotee...
SEPT 2020RiverVest Expands Analyst and Marketing & Communications Teams /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 1, 2020)ST. LOUIS, MO (September 1, 2020) – Life science venture capital firm RiverVest has expanded its team with additions to the analyst and...
JAN 2020RiverVest's Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 3, 2020) St. Louis Business JournalRead the Press ReleasePerhaps no part of the St. Louis economy surged in the past decade more...
JULY 2019Life sciences VC RiverVest Expands Team with New Managing Director and Senior Associate /*! elementor - v3.18.0 - 04-12-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (July 23, 2019)ST. LOUIS, MO (July 23, 2019) – Life sciences venture capital firm RiverVest Venture Partners today announced the...